ISSN: 1574-8863

Journal Home

Journal Guideline

Current Drug Safety Q3 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Drug Safety is a journal indexed in SJR in Pharmacology and Toxicology with an H index of 41. It has an SJR impact factor of 0,352 and it has a best quartile of Q3. It has an SJR impact factor of 0,352.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q3) Pharmacology (medical) (Q3) Pharmacology (medical) (Q3) Toxicology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,352

SJR Impact factor

41

H Index

83

Total Docs (Last Year)

127

Total Docs (3 years)

2789

Total Refs

177

Total Cites (3 years)

124

Citable Docs (3 years)

1.1

Cites/Doc (2 years)

33.6

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Toxicology Q3
Journal of Antibiotics Q3
Human Psychopharmacology Q3
Current molecular pharmacology Q3
Journal of Physiology and Pharmacology Q3

Compare this journals

Aims and Scope

Best articles by citations

A Review of Environmental Exposure to Persistent Organochlorine Residuals During the Last Fifty Years

Acknowledgement to Reviewers

Clinical Profile of Relaxin, a Possible New Drug for Human Use

Ciclesonide: A Closer Look at its Systemic and Oropharyngeal Safety Profile

Epidural Steroid Injections Do Not Induce Weight Gain

QT Alterations in Psychopharmacology: Proven Candidates and Suspects

The Modern Spectrum of Rhabdomyolysis: Drug Toxicity Revealed by Creatine Kinase Screening

Desensitization Protocol for Rituximab-Induced Serum Sickness

Recurrent Gastrointestinal Bleeding in a Patient with Eisenmenger Syndrome Using Bosentan

The Benefits and Risks of Different Therapies in Preventing Postoperative Nausea and Vomiting in Patients Undergoing Thyroid Surgery

The Detection of Adverse Events in Randomized Clinical Trials: Can we Really Say New Medicines are Safe?

QT Prolongation and Safety in the Indian Population

SHOW MORE ARTICLES

Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors

Safety of Dabigatran in an Elderly Population: Single Center Experience in Italy

Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts

Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile

The Potential of Selected Prostanoid Receptors as Targets in a New Therapeutic Strategy for Allergy and Immune Diseases

Safety of Drug Eluting Stents: Current Concerns and Controversies

Knowledge of Pharmacists about Anti-epileptic Drugs in a Developing Country

Cardiovascular Drugs Inducing QT Prolongation: Facts and Evidence

Guiding Principles of Safety as a Basis for Developing a Pharmaceutical Safety Culture

Middle-of-the-Night Administration of Sleep Medication: A Critical Review of the Effects on Next Morning Driving Ability

Emerging Anabolic Treatments in Osteoporosis

Hepatotoxicity Induced by Methimazole in a Previously Health Patient